Channels - Adjunctive Dulaglutide in Relapsing–Remitting Multiple Sclerosis: A Randomized Open-Label Proof-of-Concept Trial :: FRELIP Discovery

Similar Items: Adjunctive Dulaglutide in Relapsing–Remitting Multiple Sclerosis: A Randomized Open-Label Proof-of-Concept Trial

Quick Look
Autoinjectors for Administering Glatiramer Acetate in Relapsing Remitting Multiple Sclerosis in Europe: A Survey of Patient and Nurse Preferences
Quick Look
A Qualitative Study of Lived Treatment Experiences and Preferences of Long-Term DMT Users with Relapsing–Remitting Multiple Sclerosis
Quick Look
Summary of Research: Cognition and Employment Status of People with Relapsing Multiple Sclerosis Treated with Cladribine Tablets: Two-Year CLARIFY-MS Study
Quick Look
Correction: Stability in Cognition and Employment in People with Relapsing Multiple Sclerosis Treated with Cladribine Tablets: Two‑year Phase IV CLARIFY‑MS Study
Quick Look
Social Cognition in Multiple Sclerosis: A Multidomain Investigation
Quick Look
Dynamic Triangulation of Resting-State Networks and CSF Metabolites Reveals Bidirectional Causal Pathways in Multiple Sclerosis: A Mendelian Randomization Analysis
Quick Look
Human herpesvirus 6A and other risk factors for multiple sclerosis
Quick Look
Understanding Routine Treatment and Resource Availability for Fatigue in Multiple Sclerosis in the United Kingdom
Quick Look
Reduced Childhood Outdoor Exposure Raises Pediatric Multiple Sclerosis (PedMS) Risk
Quick Look
The hidden scale: the true contribution of primary progressive multiple sclerosis to overall disability statistics
Quick Look
Amyotrophic Lateral Sclerosis Masquerading as Multiple System Atrophy with Parkinsonism and Anxiety as Initial Manifestations
Quick Look
Integrated Transcriptome Analysis Reveals Molecular Subtypes and ceRNA Networks in Multiple Sclerosis
Quick Look
Sex-Related Differences in Circular RNA Expression in Multiple Sclerosis: A Pilot Study
Quick Look
Efficacy of Adjunctive Lumateperone 42 mg on Anhedonia and Across a Broad Range of Depressive Symptoms in Major Depressive Disorder: Post Hoc Analysis of a Phase 3, Randomized, Placebo-Controlled Trial
Quick Look
The Arm Function in Multiple Sclerosis Questionnaire (AMSQ): linguistic and cultural adaptation of the Russian-language version
Quick Look
Early Versus Delayed Treatment with Ocrelizumab: A Multicenter, Real-World Observational Study in People with Multiple Sclerosis
Quick Look
Real-World, Long-Term Outcomes with Cladribine Tablets Versus Other Oral Treatments Among Patients with Multiple Sclerosis
Quick Look
Real-World Experience of Sustained-Release Fampridine in Chinese Patients With Multiple Sclerosis: A Case Series on Walking Impairment and Fatigue
Quick Look
Using AI to Detect Psychosis Relapse: Scoping Review
Quick Look
Beyond B Cell Depletion: Adhesion and Activation Network Remodeling During Repeated Intravenous Anti-CD20 Therapy in Multiple Sclerosis
Quick Look
The Sanctuary Within: Development of CD20+ CNS Lymphoma Despite Peripheral B-Cell Depletion by Rituximab in a Multiple Sclerosis Patient
Quick Look
The Main Gaps for Randomized-controlled Trials in Psychiatry: A Bibliometric Study
Quick Look
Acupuncture for Early Parkinson’s Motor Symptoms: A Multicenter Randomized Controlled Trial Protocol
Quick Look
Prebiotics and SCFA Alleviate Parkinson’s-Related Constipation: Results from a Randomized Controlled Trial